Cycle Announces the Appointment of Angela Kurtz as Clinical Metabolic Director to lead its newly created Clinical Metabolic Department

By |2021-05-17T18:52:30+01:00December 2nd, 2020|Generics, News|

US FDA Grants Once Daily Dosing Option For NITYR (nitisinone) Tablets for HT-1 Patients

By |2021-05-17T18:52:30+01:00September 14th, 2020|Generics, News|

Dr David Buckeridge Joins Cycle Group Holdings’ Board of Directors

By |2021-05-17T18:52:31+01:00September 8th, 2020|Generics, News|

Cycle Pharmaceuticals Features in the Sunday Times Tech Track Ones to Watch 2020

By |2021-05-17T18:52:31+01:00September 8th, 2020|Generics, News|

Cycle Pharmaceuticals Secures $25 Million Debt Financing

By |2021-05-17T18:52:31+01:00September 5th, 2020|Generics, News|

Cycle Pharmaceuticals Receives FDA Approval and Launches Ketorolac Tromethamine Injection 30mg/mL in the U.S.

By |2021-05-17T18:52:31+01:00August 29th, 2018|Generics, News|

Cycle Pharmaceuticals Receives FDA Approval for Ketorolac Tromethamine Tablets in the U.S.

By |2021-05-17T18:52:31+01:00August 29th, 2018|Generics, News|
Go to Top